Nasdaq Nordic: Semi-Annual Review Of The First North 25 Index

Source: Mondo Visione 2020-06-24

Nasdaq (Nasdaq:NDAQ) announces today the updated results of the semi-annual review of the First North 25 Index (Nasdaq Stockholm: FN25) which will become effective with the market open on Wednesday, July 1, 2020.

Enzymatica AB (ENZY), Faron Pharmaceuticals Oy (FARON) and Remedy Entertainment Oyj (REMEDY) will be added to the Index.

Maha Energy AB (MAHA A), Smart Eye AB (SEYE) and Fastighets AB Trianon ser. B (TRIAN B) will be removed from the Index.

The FN25 consists of the largest and most traded shares listed on Nasdaq First North. Companies included in the FN25 are selected through a two-step process as follows:

The 30 largest companies measured by market capitalization are selected.
The 25 most traded shares within this pool, measured by aggregated trading turnover over a six month period, are selected for the index.

FN25 is reviewed semi-annually in January and July.

The First North 25 Index constituents effective July 1, 2020 are:

Absolent Group AB	Minesto AB
Admicom Oyj	Ovzon AB
Akelius Residential Property AB ser. D	Paradox Interactive AB
Amasten Fastighets AB	PowerCell Sweden AB
Cibus Nordic Real Estate AB	Remedy Entertainment Oyj
Climeon AB ser. B	Sdiptech AB ser. B
Detection Technology Oyj	Sedana Medical AB
Embracer Group AB ser. B	SpectraCure AB
Enzymatica AB	Stillfront Group AB
Faron Pharmaceuticals Oy	Storytel AB ser. B
Genovis AB	Surgical Science Sweden AB
Kambi Group Plc	Vostok Emerging Finance Ltd
Mentice AB

Nasdaq

FN25

Nasdaq Nordic: Semi-Annual Review Of The First North 25 Index

Subscribe to Our Newsletter!

Subscribe to Our Newsletter!